Research Letter
doi:10.2196/37256
Keywords
Introduction
Tools such as the Altmetric Attention Score (AAS) and Web of Science (WoS) allow researchers to qualify their work’s impact. WoS uses publication citation counts and is often utilized in academia, while the AAS analyzes online media attention to determine the impact of research [
].Methods
Using Altmetric Explorer to obtain an article’s AAS and WoS to measure an article’s citation count, the top 50 papers from each search engine were collected using the keywords “skin of color” and “dermatology.” An article’s mention in news outlets and on blogs and Twitter were recorded from Altmetric Explorer as well as whether these mentions came from members of the public or practitioners; this we defined as metrics indicative of online media “attention.” The mean (SD), 95% CI, and P values were determined by comparing the metrics provided by the top 50 papers from Altmetric and WoS.
Results
presents a comparison of the top 10 cited articles on WoS and the top 10 articles with the highest AAS.
The mean AAS for the top 50 papers from Altmetric and WoS were 39.1 and 24.2, respectively (P=.02). The P values were statistically significant in several of the categories compared, including the AAS (P=.02), news outlet mentions (P=.008), and Twitter mentions (P=.02) (
). Recurring themes in the top AAS skin-of-color (SoC) papers included skin cancer; cosmetic dermatology, notably pigmentation disorders; and inadequate knowledge among health care practitioners in identifying dermatologic conditions in SoC patients. By contrast, the top-cited SoC papers from WoS involved basic science research of dermatologic conditions and recommendations for assessment tools for clinicians and patients.Article title | Authors | Altmetric Attention Score | Total citations (on Web of Science), n | Publication year | Journal | Country | |
Top 10 Altmetric articles | |||||||
Postinflammatory hyperpigmentation: A review of the epidemiology, clinical features, and treatment options in skin of color | Davis et al [ | ]211 | 359 | 2010 | JCADa | United States | |
Acne vulgaris in skin of color: Understanding nuances and optimizing treatment outcomes | Alexis [ | ]179 | 12 | 2014 | JDDb | United States | |
Background and room illumination in color identification of skin lesions | Maymone et al [ | ]128 | 6 | 2017 | JAMAcDermatology | United States | |
Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public | Agbai et al [ | ]122 | 120 | 2014 | JAADd | United States | |
UV Exposure and the risk of cutaneous melanoma in skin of color: A systematic review | Lopes et al [ | ]102 | 7 | 2021 | JAMA Dermatology | United States | |
Skin color in dermatology textbooks: An updated evaluation and analysis | Adelekun et al [ | ]98 | 17 | 2021 | JAAD | United States | |
Skin cancer in skin of color | Bradford [ | ]80 | 196 | 2009 | Dermatology Nursing | United States | |
The use of noncultured regenerative epithelial suspension for improving skin color and scars: A report of 8 cases and review of the literature | Ren et al [ | ]72 | 2 | 2019 | Journal of CosmeticDermatology | China | |
Gaps in the understanding and treatment of skin cancer in people of color | Kailas et al [ | ]54 | 4 | 2016 | JAAD | United States | |
How dermatology is failing melanoma patients with skin of color: Unanswered questions on risk and eye-opening disparities in outcomes are weighing heavily on melanoma patients with darker skin | Nelson [ | ]53 | 3 | 2020 | Cancer Cytopathology | United States | |
Top 10 Web of Science articles | |||||||
Skin cancer in skin of color | Gloster Jr et al [ | ]26 | 301 | 2006 | JAAD | United States | |
Skin of color: Biology, structure, function, and implications for dermatologic disease | Taylor [ | ]34 | 220 | 2002 | JAAD | United States | |
A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin | Harris et al [ | ]24 | 159 | 2012 | JIDe | United States | |
Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public | Agbai et al [ | ]122 | 120 | 2014 | JAAD | United States | |
Acne vulgaris in skin of color | Taylor et al [ | ]2 | 102 | 2002 | JAAD | United States | |
The Asian dermatologic patient review of common pigmentary disorders and cutaneous diseases | Ho et al [ | ]1 | 84 | 2009 | American Journal of Clinical Dermatology | China | |
Melasma: an up-to-date comprehensive review | Ogbechie-Godec et al [ | ]10 | 61 | 2017 | Dermatology and Therapy | United States | |
Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL) | Lilly et al [ | ]2 | 61 | 2013 | JAAD | United States | |
Accuracy of self-report in assessing Fitzpatrick skin phototypes I through VI | Eilers et al [ | ]18 | 53 | 2013 | JAMA Dermatology | United States | |
Defining pseudofolliculitis barbae in 2001: A review of the literature and current trends | Perry et al [ | ]3 | 52 | 2002 | JAAD | United States |
Altmetric Attention Score | Citations | News outlet mentions | Blog mentions | Twitter mentions | Count of mentions by members of the public | Count of mentions by practitioners | |
Top 50 skin-of-color Altmetric publications, mean (95% CI) | 39.1 (27.1-51.1) | 41.9 (20.2-63.6) | 4.7 (3.0-6.4) | 0.2 (0.1-0.4) | 9.9 (6.2-13.6) | 5.6 (3.5-7.8) | 1.0 (0.5-1.5) |
Top 50 skin-of-color Web of Science publications, mean (95% CI) | 24.2 (14.6-33.8) | 46.1 (31.2-61.0) | 2.1 (1.1-3.2) | 0.2 (0.1-0.4) | 5.9 (2.9-8.8) | 4.1 (2.0-6.2) | 0.7 (0.2-1.2) |
P valuea | .02 | .34 | .008 | .42 | .02 | .17 | .11 |
aJCAD: Journal of Clinical & Aesthetic Dermatology.
bJDD: Journal of Drugs in Dermatology.
cJAMA: Journal of the American Medical Association.
dJAAD: Journal of the American Academy of Dermatology.
eJID: Journal of Investigative Dermatology.
at test.
Discussion
Principal Findings
While highly cited publications often guide clinical recommendations and carry substantial influence on practitioners, they may fail to highlight the discussions taking place outside of the scientific community [
]. For SoC patients, their interests and concerns regarding dermatologic conditions must be understood by health care providers as disease processes often manifest differently in this population compared to the general public [ ]. With over 70% of the US population using social media, these platforms will allow increased sharing of research topics, supporting the utility of Altmetric scoring compared to citation count alone [ ]. Within our study, the difference in recurrent themes between top AAS versus top-cited publications indicated that the clinical mindset and patient-centered topics may not align.Limitations and Future Work
Limitations to our study include a small sample size, narrow inclusion criteria, and a lack of time constraints. Future studies comparing AAS and WoS should be confined to a short time period to mitigate temporal confounding factors due to the differing accrual rates of citation count and AAS [
]. Medical societies and health care providers can use insights from this study to shape the practice of dermatology to better understand the interests and expectations of SoC patients.Conclusion
AAS and WoS provide different metrics on the influence of academic research. Factors that may generate greater social media attention include papers with more pictures and an author’s social media presence. Elements that may produce greater citation counts include a journal’s impact factor and an author’s academic reputation and home institution. Altmetric uniquely represents the attention of the general public, which can facilitate patient-centered decision-making.
Conflicts of Interest
RPD is editor-in-chief of JMIR Dermatology, a joint coordinating editor for Cochrane Skin, a dermatology section editor for UpToDate, a social media editor for the Journal of the American Academy of Dermatology, and a podcast editor for the Journal of Investigative Dermatology (JID). He is a coordinating editor representative on Cochrane Council. RPD receives editorial stipends (JID, JMIR Dermatology), royalties (UpToDate), and expense reimbursement from Cochrane Skin.
References
- Bernstam EV, Herskovic JR, Aphinyanaphongs Y, Aliferis CF, Sriram MG, Hersh WR. Using citation data to improve retrieval from MEDLINE. J Am Med Inform Assoc 2006;13(1):96-105 [FREE Full text] [CrossRef] [Medline]
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol 2010 Jul;3(7):20-31 [FREE Full text] [Medline]
- Alexis AF. Acne vulgaris in skin of color: understanding nuances and optimizing treatment outcomes. J Drugs Dermatol 2014 Jun;13(6):s61-s65. [Medline]
- Maymone MBC, Neamah HH, Wirya SA, Patzelt NM, Secemsky EA, Zancanaro PQ, et al. Background and room illumination in color identification of skin lesions: A cross-sectional study. JAMA Dermatol 2017 Oct 01;153(10):1059-1061 [FREE Full text] [CrossRef] [Medline]
- Agbai ON, Buster K, Sanchez M, Hernandez C, Kundu RV, Chiu M, et al. Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public. J Am Acad Dermatol 2014 Apr;70(4):748-762. [CrossRef] [Medline]
- Lopes FCPS, Sleiman MG, Sebastian K, Bogucka R, Jacobs EA, Adamson AS. UV Exposure and the risk of cutaneous melanoma in skin of color: A systematic review. JAMA Dermatol 2021 Feb 01;157(2):213-219. [CrossRef] [Medline]
- Adelekun A, Onyekaba G, Lipoff JB. Skin color in dermatology textbooks: An updated evaluation and analysis. J Am Acad Dermatol 2021 Jan;84(1):194-196. [CrossRef] [Medline]
- Bradford PT. Skin cancer in skin of color. Dermatol Nurs 2009;21(4):170-7, 206; quiz 178 [FREE Full text] [Medline]
- Ren J, Liu J, Yu N, Zhang W, Qian H, Liu Z, et al. The use of noncultured regenerative epithelial suspension for improving skin color and scars: A report of 8 cases and review of the literature. J Cosmet Dermatol 2019 Jul 26. [CrossRef] [Medline]
- Kailas A, Solomon JA, Mostow EN, Rigel DS, Kittles R, Taylor SC. Gaps in the understanding and treatment of skin cancer in people of color. J Am Acad Dermatol 2016 May;74(5):1020-1021. [CrossRef] [Medline]
- Nelson B. How dermatology is failing melanoma patients with skin of color: Unanswered questions on risk and eye-opening disparities in outcomes are weighing heavily on melanoma patients with darker skin. In this article, part 1 of a 2-part series, we explore the deadly consequences of racism and inequality in cancer care. Cancer Cytopathol 2020 Jan;128(1):7-8 [FREE Full text] [CrossRef] [Medline]
- Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006 Nov;55(5):741-60; quiz 761. [CrossRef] [Medline]
- Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol 2002 Mar;46(2 Suppl Understanding):S41-S62. [CrossRef] [Medline]
- Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin. J Invest Dermatol 2012 Jul;132(7):1869-1876 [FREE Full text] [CrossRef] [Medline]
- Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol 2002 Mar;46(2 Suppl Understanding):S98-106. [CrossRef] [Medline]
- Ho SGY, Chan HHL. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol 2009;10(3):153-168. [CrossRef] [Medline]
- Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatol Ther (Heidelb) 2017 Sep;7(3):305-318 [FREE Full text] [CrossRef] [Medline]
- Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol 2013 Jul;69(1):e11-e18. [CrossRef] [Medline]
- Eilers S, Bach DQ, Gaber R, Blatt H, Guevara Y, Nitsche K, et al. Accuracy of self-report in assessing Fitzpatrick skin phototypes I through VI. JAMA Dermatol 2013 Nov;149(11):1289-1294. [CrossRef] [Medline]
- Perry PK, Cook-Bolden FE, Rahman Z, Jones E, Taylor SC. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol 2002 Mar;46(2 Suppl Understanding):S113-S119. [CrossRef] [Medline]
- Chavarro D, Ràfols I, Tang P. To what extent is inclusion in the Web of Science an indicator of journal ‘quality’? Res Eval 2018;27(2):106-118. [CrossRef]
- Dean B. How Many People Use Social Media in 2021? (65+ Statistics). Backlinko. 2021 Oct 10. URL: https://backlinko.com/social-media-users [accessed 2022-01-02]
- Huang A, Weng CY. Correspondence. Retina 2022 Jun 01;42(6):e30. [CrossRef] [Medline]
Abbreviations
AAS: Altmetric Attention Score |
SoC: skin of color |
WoS: Web of Science |
Edited by R Alhusayen; submitted 14.02.22; peer-reviewed by J Lipoff, A Huang; comments to author 18.05.22; revised version received 22.05.22; accepted 23.05.22; published 06.06.22
Copyright©Benjamin R Cooper, Jaclyn B Anderson, Melissa R Laughter, Colby L Presley, J Mark Albrecht, Robert P Dellavalle. Originally published in JMIR Dermatology (http://derma.jmir.org), 06.06.2022.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Dermatology Research, is properly cited. The complete bibliographic information, a link to the original publication on http://derma.jmir.org, as well as this copyright and license information must be included.